Literature DB >> 26678280

Airway Vagal Neuroplasticity Associated with Respiratory Viral Infections.

Eric J Zaccone1, Bradley J Undem2.   

Abstract

Respiratory virus infections leads to coughing, sneezing, and increases in reflex parasympathetic bronchoconstriction and secretions. These responses to viral infection are exclusively or largely secondary to changes in the function of the nervous system. For many with underlying airway pathologies such as asthma and COPD, this neuroplasticity can lead to disease exacerbations and hospitalization. Relatively little is understood about the cellular and molecular mechanisms that underlie the changes in neuronal control of the respiratory tract during viral infection, but the evidence supports the idea that changes occur in the physiology of both the sensory and autonomic innervation. Virus infection can lead to acute increases in the activity of sensory nerves as well as to genetic changes causing alterations in sensory nerve phenotype. In addition, respiratory viral infections are associated with changes in the control of neurotransmitter release from cholinergic nerve endings terminating at the level of the airway smooth muscle.

Entities:  

Keywords:  Airway sensory nerves; Brain-derived neurotrophic growth factor; Cough; Nodose; Respiratory virus; TRPV1; Vagal afferent

Mesh:

Year:  2015        PMID: 26678280      PMCID: PMC4827158          DOI: 10.1007/s00408-015-9832-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  43 in total

Review 1.  Neurotrophin signaling via long-distance axonal transport.

Authors:  Praveen D Chowdary; Dung L Che; Bianxiao Cui
Journal:  Annu Rev Phys Chem       Date:  2012-01-30       Impact factor: 12.703

Review 2.  Autonomic neural control of intrathoracic airways.

Authors:  Bradley J Undem; Carl Potenzieri
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

3.  Neurotrophin and GDNF family ligand receptor expression in vagal sensory nerve subtypes innervating the adult guinea pig respiratory tract.

Authors:  Tinamarie Lieu; Marian Kollarik; Allen C Myers; Bradley J Undem
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-02-18       Impact factor: 5.464

Review 4.  Sensory nerves in lung and airways.

Authors:  Lu-Yuan Lee; Jerry Yu
Journal:  Compr Physiol       Date:  2014-01       Impact factor: 9.090

5.  Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways.

Authors:  Dimitri Tränkner; Nadeau Hahne; Ken Sugino; Mark A Hoon; Charles Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

6.  Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation.

Authors:  A Fischer; G P McGregor; A Saria; B Philippin; W Kummer
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

7.  Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons.

Authors:  S Neumann; T P Doubell; T Leslie; C J Woolf
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

8.  Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin.

Authors:  Megan Grace; Mark A Birrell; Eric Dubuis; Sarah A Maher; Maria G Belvisi
Journal:  Thorax       Date:  2012-06-12       Impact factor: 9.139

Review 9.  Viruses and asthma.

Authors:  Daniel E Dulek; R Stokes Peebles
Journal:  Biochim Biophys Acta       Date:  2011-02-01

Review 10.  Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

View more
  11 in total

1.  Abstracts from the Fifth American Cough Conference.

Authors:  Franklin McCool
Journal:  Lung       Date:  2016-02       Impact factor: 2.584

2.  Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients.

Authors:  Arschang Valipour; Pallav L Shah; Christophe Pison; Vincent Ninane; Wim Janssens; Thierry Perez; Romain Kessler; Gaetan Deslee; Justin Garner; Christine Abele; Jorine E Hartman; Dirk-Jan Slebos
Journal:  Respiration       Date:  2019-06-20       Impact factor: 3.580

3.  Activation of a nerve injury transcriptional signature in airway-innervating sensory neurons after lipopolysaccharide-induced lung inflammation.

Authors:  Melanie Maya Kaelberer; Ana Isabel Caceres; Sven-Eric Jordt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

Review 4.  Neuro-immune regulation of mucosal physiology.

Authors:  Julie Chesné; Vânia Cardoso; Henrique Veiga-Fernandes
Journal:  Mucosal Immunol       Date:  2018-08-08       Impact factor: 7.313

Review 5.  TRP channels in airway sensory nerves.

Authors:  Qihai Gu; Lu-Yuan Lee
Journal:  Neurosci Lett       Date:  2021-02-12       Impact factor: 3.046

6.  Lower respiratory tract infections in early life are associated with obstructive sleep apnea diagnosis during childhood in a large birth cohort.

Authors:  Maria J Gutierrez; Gustavo Nino; Jeremy S Landeo-Gutierrez; Miriam R Weiss; Diego A Preciado; Xiumei Hong; Xiaobin Wang
Journal:  Sleep       Date:  2021-12-10       Impact factor: 6.313

7.  Targeted lung denervation in sheep: durability of denervation and long-term histologic effects on bronchial wall and peribronchial structures.

Authors:  Martin L Mayse; Holly S Norman; Alexander D Peterson; Kristina T Rouw; Philip J Johnson
Journal:  Respir Res       Date:  2020-05-18

8.  Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3).

Authors:  Dirk-Jan Slebos; Bruno Degano; Arschang Valipour; Pallav L Shah; Gaetan Deslée; Frank C Sciurba
Journal:  BMC Pulm Med       Date:  2020-02-13       Impact factor: 3.317

9.  Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.

Authors:  Dirk-Jan Slebos; Pallav L Shah; Felix J F Herth; Christophe Pison; Christian Schumann; Ralf-Harto Hübner; Peter I Bonta; Romain Kessler; Wolfgang Gesierich; Kaid Darwiche; Bernd Lamprecht; Thierry Perez; Dirk Skowasch; Gaetan Deslee; Armelle Marceau; Frank C Sciurba; Reinoud Gosens; Jorine E Hartman; Karthi Srikanthan; Marina Duller; Arschang Valipour
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

10.  Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2.

Authors:  Arschang Valipour; Pallav L Shah; Felix J Herth; Christophe Pison; Christian Schumann; Ralf-Harto Hübner; Peter I Bonta; Romain Kessler; Wolfgang Gesierich; Kaid Darwiche; Bernd Lamprecht; Thierry Perez; Dirk Skowasch; Gaetan Deslee; Armelle Marceau; Frank C Sciurba; Reinoud Gosens; Jorine E Hartman; Francesca Conway; Marina Duller; Martin Mayse; Holly S Norman; Dirk-Jan Slebos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.